Cal-Maine Foods Inc. Common Stock (CALM) fair value
Consumer Defensive · Farm Products · NASDAQ · United States
$62.60-1.93%
Market cap $2.9BNext earnings 2026-09-30Updated Oct 19, 2026
Our verdict
Trades 18% below our fair value
Price
$62.60
Model fair valueConfidence: good
$75.91
Model range
$19.44 to $139
Fair value $75.91
Price $62.60
3 models fit Cal-Maine Foods Inc. Common Stock and they disagree: 1 of 3 land within 15% of the average.
Two or more of our models back this value.
Discount(i)Bronze47
Valued as a mature, profitable company: Discounted cash flow, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionCal-Maine Foods Inc. Common Stock (CALM)
Fair value (3 models)
$75.91
ACCE price target
$57.90
Rating
Undervalued
Horizon
12 months
Fair value published on 19 Oct 2026, 18:04 CEST; previously $82.96 since 11 Oct 2026, 00:00 CEST.
ACCE price target published on 18 Oct 2026, 00:00 CEST; previously $62.00 since 17 May 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 18:04 CEST.
Price used: $62.60 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, Graham number, and Dividend discount.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
17.5% below
+21.3% to fair value
ACCE score
29
out of 100
Analysts
0% buy
4 covering
P/E
50.9x
forward 61.7x
1-year return
-29.9%
Dividend yield
3.84%
Cal-Maine Foods Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Cal-Maine Foods is the largest U.S. producer of shell eggs, selling branded and private-label cartons to retail and foodservice customers, with a flock large enough to make it a price-setter in a commodity market. Its moat is scale and cost position rather than brand, and that matters most when egg prices are high and rivals cannot restock quickly. The current picture is a cyclical trough: revenue is down 41.5% year on year, gross margin is 14.3%, and operating margin is negative at -15.1%, so trailing earnings look expensive at 51.7 times while the forward multiple of 19.8 implies the market expects a recovery. The thesis depends on flock rebuilding and egg prices normalising, which would restore operating leverage quickly given the fixed-cost structure. The score of 29/100 and absence from any index mean the name has little institutional support and the debate is still open. It merits a deeper look only if you have a view on the egg cycle and can underwrite the timing of that recovery.